Solventum earnings were $479.0M for the trailing 12 months ending Dec 31, 2024, with -64.4% growth year over year. The latest SOLV earnings report on Dec 31, 2024 announced Q4 2024 earnings of $31.0M, down 74.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SOLV reported annual earnings of $479.0M, with -64.4% growth.
SOLV past earnings growth
How has SOLV's earnings growth performed historically?
Solventum (NYSE: SOLV) reported Q4 2024 earnings per share (EPS) of $0.18, up 88.54% year over year. Total SOLV earnings for the quarter were $31.00 million. In the same quarter last year, Solventum's earnings per share (EPS) was $1.57.
As of the last Solventum earnings report, Solventum is currently profitable. Solventum's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $479.00 million, a 64.41% decrease year over year.
What was SOLV's earnings growth in the past year?
As of Solventum's earnings date in Q2 2025, Solventum's earnings has grown -64.44% year over year. This is 84.55 percentage points lower than the US Health Information Services industry earnings growth rate of 20.11%. SOLV earnings in the past year totalled $479.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.